0001209191-16-108186.txt : 20160314
0001209191-16-108186.hdr.sgml : 20160314
20160314174211
ACCESSION NUMBER: 0001209191-16-108186
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160310
FILED AS OF DATE: 20160314
DATE AS OF CHANGE: 20160314
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AQUINOX PHARMACEUTICALS, INC
CENTRAL INDEX KEY: 0001404644
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 887 GREAT NORTHERN WAY
STREET 2: SUITE 450
CITY: VANCOUVER
STATE: A1
ZIP: V5T 4T5
BUSINESS PHONE: 604-629-9223
MAIL ADDRESS:
STREET 1: 887 GREAT NORTHERN WAY
STREET 2: SUITE 450
CITY: VANCOUVER
STATE: A1
ZIP: V5T 4T5
FORMER COMPANY:
FORMER CONFORMED NAME: AQUINOX PHARMACEUTICALS (USA) INC
DATE OF NAME CHANGE: 20070626
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SHREWSBURY STEPHEN B
CENTRAL INDEX KEY: 0001413821
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36327
FILM NUMBER: 161504955
MAIL ADDRESS:
STREET 1: 2400 BAYSHORE PARKWAY
STREET 2: SUITE 200
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-03-10
0
0001404644
AQUINOX PHARMACEUTICALS, INC
AQXP
0001413821
SHREWSBURY STEPHEN B
C/O AQUINOX PHARMACEUTICALS, INC.
450 - 887 GREAT NORTHERN WAY
VANCOUVER
A1
V5T 4T5
BRITISH COLUMBIA, CANADA
0
1
0
0
CMO; Senior VP Clinical Dev.
Stock Option (Right to Buy)
8.08
2016-03-10
4
A
0
35000
0.00
A
2026-03-09
Common Stock
35000
35000
D
The shares subject to this option shall vest and become exercisable at a rate of twenty-five percent of the total number of shares underlying the options on the one-year anniversary of the vesting commencement date and 1/48th of the total number of shares underlying the options each monthly anniversary of the vesting commencement date thereafter for so long as the recipient of the option provides continuous service to the issuer, such that the total number of shares underlying the options shall be fully vested on the four-year anniversary of the vesting commencement date.
/s/ Stephen Shrewsbury
2016-03-14